Opportunity ID: 362302
General Information
| Funding Opportunity Number | HT942526TERPCTA |
| Funding Opportunity Title | DoW Toxic Exposures Clinical Trial Award |
| Agency | Ebony S Simmons Grantor |
| Document Type | synopsis |
| Version | 3 |
| Opportunity Category | Discretionary |
| Opportunity Category Explanation | Not specified |
| Funding Instrument Type | Grant |
| Category of Funding Activity | Science and Technology and other Research and Development |
| Category Explanation | Not specified |
| Expected Number of Awards | 1 |
| Cost Sharing or Matching Requirement | No |
| Posted Date | May 21, 2026 12:00:00 AM EDT |
| Last Updated Date | May 21, 2026 01:40:32 PM EDT |
| Original Closing Date | Nov 19, 2026 12:00:00 AM EST |
| Original Closing Date Notes | Not specified |
| Current Closing Date | Nov 19, 2026 12:00:00 AM EST |
| Current Closing Date Notes | Not specified |
| Estimated Synopsis Date | Not specified |
| Estimated Application Due Date | Not specified |
| Estimated Award Date | Not specified |
| Estimated Project Start Date | Not specified |
| Archive Date | Dec 19, 2026 12:00:00 AM EST |
| Estimated Total Program Funding | 4,500,000 |
| Award Ceiling | none |
| Award Floor | none |
Assistance Listings
- 12.420 — Military Medical Research and Development
Eligibility
| Eligible Applicants | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
Description
Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials (including pragmatic clinical trials) to determine efficacy in relevant patient populations.
Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP CTA includes a Partnering Principal Investigator Option (PPIO). One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising interventions/knowledge products into clinical applications. Partnering should significantly advance the research beyond what would be possible through independent efforts.
https://cdmrp.health.mil/pubs/press/2026/terppreann
Additional Information
| Contact | Ebony S Simmons Grantor |
| Contact Information | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| help@eBRAP.org | |
| Email Description | eBRAP Help Desk |
| Phone | 301-619-2105 |
Additional information
Version History
Version history
| Opp hist id / Opportunity id | 362302 |
| Opp hist id / Revision | 1 |
| Opportunity id | 362302 |
| Revision | 1 |
| Opportunity number | HT942526TERPCTA |
| Opportunity title | DoW Toxic Exposures Clinical Trial Award |
| Owning agency code | DOD-AMRAA |
| Opportunity category / Category | D |
| Opportunity category / Description | Discretionary |
| Forecast / Opp hist id / Opportunity id | 362302 |
| Forecast / Opp hist id / Revision | 1 |
| Forecast / Opportunity id | 362302 |
| Forecast / Revision | 1 |
| Forecast / Version | 1 |
| Forecast / Posting date | May 07, 2026 12:00:00 AM EDT |
| Forecast / Forecast desc | Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials (including pragmatic clinical trials) to determine efficacy in relevant patient populations.
Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP CTA includes a Partnering Principal Investigator Option (PPIO). One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising interventions/knowledge products into clinical applications. Partnering should significantly advance the research beyond what would be possible through independent efforts. https://cdmrp.health.mil/pubs/press/2026/terppreann |
| Forecast / Cost sharing | No |
| Forecast / Number of awards | 1 |
| Forecast / Estimated funding | 4500000 |
| Forecast / Award ceiling | none |
| Forecast / Award floor | none |
| Forecast / Agency contact name | eBRAP Help Desk |
| Forecast / Agency contact phone | 301-682-5507 |
| Forecast / Agency contact email | help@ebrap.org |
| Forecast / Agency contact email desc | eBRAP Help Desk |
| Forecast / Agency code | DOD-AMRAA |
| Forecast / Applicant eligibility desc | Not specified |
| Forecast / Est synopsis posting date | Jul 08, 2026 12:00:00 AM EDT |
| Forecast / Est application response date | Nov 19, 2026 12:00:00 AM EST |
| Forecast / Est application response date desc | Not specified |
| Forecast / Est award date | Sep 30, 2027 12:00:00 AM EDT |
| Forecast / Est project start date | Sep 30, 2027 12:00:00 AM EDT |
| Forecast / Fiscal year | 2026 |
| Forecast / Create time stamp | May 07, 2026 11:11:30 AM EDT |
| Forecast / Action type | U |
| Forecast / Action date | May 21, 2026 01:20:39 PM EDT |
| Forecast / Created date | May 07, 2026 11:09:36 AM EDT |
| Forecast / Last updated date | May 07, 2026 11:11:30 AM EDT |
| Forecast / Agency details / Code | AMRAA |
| Forecast / Agency details / Seed | DOD-AMRAA |
| Forecast / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Forecast / Agency details / Agency code | DOD-AMRAA |
| Forecast / Agency details / Top agency code | DOD |
| Forecast / Estimated funding formatted | 4,500,000 |
| Forecast / Applicant types 1 / Id | 99 |
| Forecast / Applicant types 1 / Description | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Forecast / Funding instruments 1 / Id | G |
| Forecast / Funding instruments 1 / Description | Grant |
| Forecast / Funding activity categories 1 / Id | ST |
| Forecast / Funding activity categories 1 / Description | Science and Technology and other Research and Development |
| Forecast / Posting date str | 2026-05-07-00-00-00 |
| Forecast / Est synopsis posting date str | 2026-07-08-00-00-00 |
| Forecast / Est application response date str | 2026-11-19-00-00-00 |
| Forecast / Est award date str | 2027-09-30-00-00-00 |
| Forecast / Est project start date str | 2027-09-30-00-00-00 |
| Forecast / Create time stamp str | 2026-05-07-11-11-30 |
| Cfdas 1 / Id | 433219 |
| Cfdas 1 / Opportunity id | 362302 |
| Cfdas 1 / Revision | 4 |
| Cfdas 1 / Cfda number | 12.420 |
| Cfdas 1 / Program title | Military Medical Research and Development |
| Synopsis modified fields | Not specified |
| Forecast modified fields | Not specified |
Attachment changes
| Id / Opportunity id | 362302 |
| Id / Att type | D |
| Id / Created date | May 21, 2026 01:27:39 PM EDT |
| Id / Att type desc | Related Documents |
| Id / Comments date | May 21, 2026 |
| Change comments | Modification created to add the Program Announcement. |
Forecast changes
revision
version
forecastDesc
archiveDate
modComments
createTimeStamp
| Id | 362302 |
| Revision | 5 |
| Opportunity number | HT942526TERPCTA |
| Opportunity title | DoW Toxic Exposures Clinical Trial Award |
| Owning agency code | DOD-AMRAA |
| Opportunity category / Category | D |
| Opportunity category / Description | Discretionary |
| Synopsis / Opportunity id | 362302 |
| Synopsis / Version | 3 |
| Synopsis / Agency code | DOD-AMRAA |
| Synopsis / Agency name | Ebony S Simmons Grantor |
| Synopsis / Agency phone | 301-619-2105 |
| Synopsis / Agency address desc | eBRAP Help Desk |
| Synopsis / Agency details / Code | AMRAA |
| Synopsis / Agency details / Seed | DOD-AMRAA |
| Synopsis / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Synopsis / Agency details / Agency code | DOD-AMRAA |
| Synopsis / Agency details / Top agency code | DOD |
| Synopsis / Top agency details / Code | DOD |
| Synopsis / Top agency details / Seed | DOD |
| Synopsis / Top agency details / Agency name | Department of Defense |
| Synopsis / Top agency details / Agency code | DOD |
| Synopsis / Top agency details / Top agency code | DOD |
| Synopsis / Agency contact phone | 301-619-2105 |
| Synopsis / Agency contact name | Ebony S Simmons Grantor |
| Synopsis / Agency contact desc | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Synopsis / Agency contact email | help@eBRAP.org |
| Synopsis / Agency contact email desc | eBRAP Help Desk |
| Synopsis / Synopsis desc | Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials (including pragmatic clinical trials) to determine efficacy in relevant patient populations.
Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP CTA includes a Partnering Principal Investigator Option (PPIO). One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising interventions/knowledge products into clinical applications. Partnering should significantly advance the research beyond what would be possible through independent efforts. https://cdmrp.health.mil/pubs/press/2026/terppreann |
| Synopsis / Response date | Nov 19, 2026 12:00:00 AM EST |
| Synopsis / Response date desc | Not specified |
| Synopsis / Posting date | May 21, 2026 12:00:00 AM EDT |
| Synopsis / Archive date | Dec 19, 2026 12:00:00 AM EST |
| Synopsis / Cost sharing | No |
| Synopsis / Number of awards | 1 |
| Synopsis / Estimated funding | 4500000 |
| Synopsis / Estimated funding formatted | 4,500,000 |
| Synopsis / Award ceiling | none |
| Synopsis / Award floor | none |
| Synopsis / Applicant eligibility desc | Not specified |
| Synopsis / Create time stamp | May 21, 2026 01:40:32 PM EDT |
| Synopsis / Created date | May 21, 2026 01:40:32 PM EDT |
| Synopsis / Last updated date | May 21, 2026 01:40:32 PM EDT |
| Synopsis / Applicant types 1 / Id | 99 |
| Synopsis / Applicant types 1 / Description | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Synopsis / Funding instruments 1 / Id | G |
| Synopsis / Funding instruments 1 / Description | Grant |
| Synopsis / Funding activity categories 1 / Id | ST |
| Synopsis / Funding activity categories 1 / Description | Science and Technology and other Research and Development |
| Synopsis / Response date str | 2026-11-19-00-00-00 |
| Synopsis / Posting date str | 2026-05-21-00-00-00 |
| Synopsis / Archive date str | 2026-12-19-00-00-00 |
| Synopsis / Create time stamp str | 2026-05-21-13-40-32 |
| Agency details / Code | AMRAA |
| Agency details / Seed | DOD-AMRAA |
| Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Agency details / Agency code | DOD-AMRAA |
| Agency details / Top agency code | DOD |
| Top agency details / Code | DOD |
| Top agency details / Seed | DOD |
| Top agency details / Agency name | Department of Defense |
| Top agency details / Agency code | DOD |
| Top agency details / Top agency code | DOD |
| Forecast / Opportunity id | 362302 |
| Forecast / Version | 2 |
| Forecast / Posting date | May 07, 2026 12:00:00 AM EDT |
| Forecast / Archive date | May 20, 2026 12:00:00 AM EDT |
| Forecast / Forecast desc | Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials (including pragmatic clinical trials) to determine efficacy in relevant patient populations.
Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP CTA includes a Partnering Principal Investigator Option (PPIO). One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising interventions/knowledge products into clinical applications. Partnering should significantly advance the research beyond what would be possible through independent efforts. https://cdmrp.health.mil/pubs/press/2026/terppreann |
| Forecast / Cost sharing | No |
| Forecast / Number of awards | 1 |
| Forecast / Estimated funding | 4500000 |
| Forecast / Award ceiling | none |
| Forecast / Award floor | none |
| Forecast / Agency contact name | eBRAP Help Desk |
| Forecast / Agency contact phone | 301-682-5507 |
| Forecast / Agency contact email | help@ebrap.org |
| Forecast / Agency contact email desc | eBRAP Help Desk |
| Forecast / Agency code | DOD-AMRAA |
| Forecast / Applicant eligibility desc | Not specified |
| Forecast / Est synopsis posting date | Jul 08, 2026 12:00:00 AM EDT |
| Forecast / Est application response date | Nov 19, 2026 12:00:00 AM EST |
| Forecast / Est application response date desc | Not specified |
| Forecast / Est award date | Sep 30, 2027 12:00:00 AM EDT |
| Forecast / Est project start date | Sep 30, 2027 12:00:00 AM EDT |
| Forecast / Fiscal year | 2026 |
| Forecast / Mod comments | Updated Archive Date |
| Forecast / Create time stamp | May 21, 2026 01:27:39 PM EDT |
| Forecast / Created date | May 07, 2026 11:09:36 AM EDT |
| Forecast / Last updated date | May 21, 2026 01:27:39 PM EDT |
| Forecast / Agency details / Code | AMRAA |
| Forecast / Agency details / Seed | DOD-AMRAA |
| Forecast / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Forecast / Agency details / Agency code | DOD-AMRAA |
| Forecast / Agency details / Top agency code | DOD |
| Forecast / Estimated funding formatted | 4,500,000 |
| Forecast / Applicant types 1 / Id | 99 |
| Forecast / Applicant types 1 / Description | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Forecast / Funding instruments 1 / Id | G |
| Forecast / Funding instruments 1 / Description | Grant |
| Forecast / Funding activity categories 1 / Id | ST |
| Forecast / Funding activity categories 1 / Description | Science and Technology and other Research and Development |
| Forecast / Posting date str | 2026-05-07-00-00-00 |
| Forecast / Archive date str | 2026-05-20-00-00-00 |
| Forecast / Est synopsis posting date str | 2026-07-08-00-00-00 |
| Forecast / Est application response date str | 2026-11-19-00-00-00 |
| Forecast / Est award date str | 2027-09-30-00-00-00 |
| Forecast / Est project start date str | 2027-09-30-00-00-00 |
| Forecast / Create time stamp str | 2026-05-21-13-27-39 |
| Synopsis attachment folders 1 / Id | 79854 |
| Synopsis attachment folders 1 / Opportunity id | 362302 |
| Synopsis attachment folders 1 / Folder type | Full Announcement |
| Synopsis attachment folders 1 / Folder name | FY26 TERP CTA |
| Synopsis attachment folders 1 / Zip lob size | 667203 |
| Synopsis attachment folders 1 / Created date | May 21, 2026 01:22:46 PM EDT |
| Synopsis attachment folders 1 / Last updated date | May 21, 2026 01:24:01 PM EDT |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Id | 352353 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Opportunity id | 362302 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Mime type | application/pdf |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File name | HT942526TERPCTA_GG.pdf |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File description | FY26 TERP CTA Program Announcement |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File lob size | 865068 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Created date | May 21, 2026 01:24:01 PM EDT |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Synopsis att folder id | 79854 |
| Synopsis document urls | Not specified |
| Syn att change comments 1 / Id / Opportunity id | 362302 |
| Syn att change comments 1 / Id / Att type | D |
| Syn att change comments 1 / Id / Created date | May 21, 2026 01:27:39 PM EDT |
| Syn att change comments 1 / Id / Att type desc | Related Documents |
| Syn att change comments 1 / Id / Comments date | May 21, 2026 |
| Syn att change comments 1 / Change comments | Modification created to add the Program Announcement. |
| Cfdas 1 / Id | 433219 |
| Cfdas 1 / Opportunity id | 362302 |
| Cfdas 1 / Cfda number | 12.420 |
| Cfdas 1 / Program title | Military Medical Research and Development |
| Opportunity pkgs 1 / Id | 292894 |
| Opportunity pkgs 1 / Topportunity id | 362302 |
| Opportunity pkgs 1 / Family id | 14 |
| Opportunity pkgs 1 / Dialect | XFDL2.2 |
| Opportunity pkgs 1 / Opportunity number | HT942526TERPCTA |
| Opportunity pkgs 1 / Opportunity title | DoW Toxic Exposures Clinical Trial Award |
| Opportunity pkgs 1 / Cfda number | 12.420 |
| Opportunity pkgs 1 / Opening date | 2026-05-21 |
| Opportunity pkgs 1 / Closing date | 2026-11-19 |
| Opportunity pkgs 1 / Owning agency code | DOD-AMRAA |
| Opportunity pkgs 1 / Agency details / Code | AMRAA |
| Opportunity pkgs 1 / Agency details / Seed | DOD-AMRAA |
| Opportunity pkgs 1 / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Opportunity pkgs 1 / Agency details / Agency code | DOD-AMRAA |
| Opportunity pkgs 1 / Agency details / Top agency code | DOD |
| Opportunity pkgs 1 / Top agency details / Code | DOD |
| Opportunity pkgs 1 / Top agency details / Seed | DOD |
| Opportunity pkgs 1 / Top agency details / Agency name | Department of Defense |
| Opportunity pkgs 1 / Top agency details / Agency code | DOD |
| Opportunity pkgs 1 / Top agency details / Top agency code | DOD |
| Opportunity pkgs 1 / Program title | Military Medical Research and Development |
| Opportunity pkgs 1 / Contact info | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Opportunity pkgs 1 / Electronic required | Y |
| Opportunity pkgs 1 / Expected application count | 1 |
| Opportunity pkgs 1 / Expected application size | 1000000 |
| Opportunity pkgs 1 / Open to applicant type | 1 |
| Opportunity pkgs 1 / Is multi project | N |
| Opportunity pkgs 1 / Extension | |
| Opportunity pkgs 1 / Mimetype | application/pdf |
| Opportunity pkgs 1 / Last update | May 21, 2026 01:59:53 PM EDT |
| Opportunity pkgs 1 / Workspace compatible flag | Y |
| Opportunity pkgs 1 / Package id | PKG00292894 |
| Opportunity pkgs 1 / Opening date str | 2026-05-21-00-00-00 |
| Opportunity pkgs 1 / Closing date str | 2026-11-19-00-00-00 |
| Closed opportunity pkgs | Not specified |
| Original due date | Nov 19, 2026 12:00:00 AM EST |
| Original due date desc | Not specified |
| Synopsis modified fields | Not specified |
| Forecast modified fields | revision; version; forecastDesc; archiveDate; modComments; createTimeStamp |
| Error messages | Not specified |
| Syn post date in past | Yes |
| Doc type | synopsis |
| Forecast hist count | 0 |
| Synopsis hist count | 0 |
| Assist compatible | No |
| Assist url | Not specified |
| Related opps | Not specified |
| Ost | POSTED |
Related Documents
HT942526TERPCTA_GG.pdf
Packages
| Agency Contact Information: | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00292894 | 2026-05-21 | 2026-11-19 | View |
Package 1
Instructions
PKG00292894-instructions.pdf
Mandatory forms
RR_SF424_5_0-V5.0.pdf
AttachmentForm_1_2-V1.2.pdf
RR_KeyPersonExpanded_4_0-V4.0.pdf
RR_Budget_3_0-V3.0.pdf
PerformanceSite_4_0-V4.0.pdf
Optional forms
RR_SubawardBudget30_3_0-V3.0.pdf
